
Présentation
Team leader
https://cvscience.aviesan.fr/cv/507/stephane-martin
https://scholar.google.com/S_Martin
Publications
2024
Molecular Organization and Regulation of the Mammalian Synapse by the Post-Translational Modification SUMOylation.,
Cells 2024 Feb; 13(5): .
2022
Translational Research Methods in Neurodevelopmental Disorders (2022),
.
2022
Bidirectional regulation of synaptic SUMOylation by Group 1 metabotropic glutamate receptors.,
Cell Mol Life Sci 2022 Jun; 79(7): 378.
2022
Combining affinity purification and mass spectrometry to define the network of the nuclear proteins interacting with the N-terminal region of FMRP.,
Front Mol Biosci 2022 ; 9(): 954087.
2021
Missense mutation of Fmr1 results in impaired AMPAR-mediated plasticity and socio-cognitive deficits in mice.,
Nat Commun 2021 Mar; 12(1): 1557.
2021
Proteomic Identification of an Endogenous Synaptic SUMOylome in the Developing Rat Brain.,
Front Mol Neurosci 2021 ; 14(): 780535.
2020
Post-translational modifications of the Fragile X Mental Retardation Protein in neuronal function and dysfunction.,
Mol Psychiatry 2020 Aug; 25(8): 1688-1703.
2019
Involvement of Phosphodiesterase 2A Activity in the Pathophysiology of Fragile X Syndrome,
Cerebral Cortex, 2019, 29 (8), pp.3241-3252. ⟨10.1093/cercor/bhy192⟩.
2019
The synaptic balance between sumoylation and desumoylation is maintained by the activation of metabotropic mGlu5 receptors.,
Cell Mol Life Sci 2019 Aug; 76(15): 3019-3031.
2018
Ptchd1 deficiency induces excitatory synaptic and cognitive dysfunctions in mouse.,
Mol Psychiatry 2018 May; 23(5): 1356-1367.
2018
Sumoylation regulates FMRP-mediated dendritic spine elimination and maturation.,
Nat Commun 2018 Feb; 9(1): 757.
2018
New Insights Into the Role of Cav2 Protein Family in Calcium Flux Deregulation in Fmr1-KO Neurons.,
Front Mol Neurosci 2018 ; 11(): 342.
2017
Commentary: Analysis of SUMO1-conjugation at synapses.,
Front Cell Neurosci 2017 ; 11(): 345.
2016
Interactions between N-Ethylmaleimide-sensitive factor and GluA2 contribute to effects of glucocorticoid hormones on AMPA receptor function in the rodent hippocampus.,
Hippocampus 2016 Jul; 26(7): 848-56.
2016
Sumoylation in Synaptic Function and Dysfunction.,
Front Synaptic Neurosci 2016 ; 8(): 9.
2015
mTOR is essential for corticosteroid effects on hippocampal AMPA receptor function and fear memory.,
Learn Mem 2015 Dec; 22(12): 577-83.
2015
In vitro and in vivo regulation of synaptogenesis by the novel antidepressant spadin.,
Br J Pharmacol 2015 May; 172(10): 2604-17.
2015
Tracking the activity-dependent diffusion of synaptic proteins using restricted photoconversion of Dendra2.,
Front Cell Neurosci 2015 ; 9(): 367.
2014
mGlu5 receptors regulate synaptic sumoylation via a transient PKC-dependent diffusional trapping of Ubc9 into spines.,
Nat Commun 2014 Oct; 5(): 5113.
2013
Protein sumoylation in brain development, neuronal morphology and spinogenesis.,
Neuromolecular Med 2013 Dec; 15(4): 677-91.
2013
Activity-dependent regulation of the sumoylation machinery in rat hippocampal neurons.,
Biol Cell 2013 Jan; 105(1): 30-45.
2012
Developmental regulation and spatiotemporal redistribution of the sumoylation machinery in the rat central nervous system.,
PLoS One 2012 ; 7(3): e33757.
2012
Regulation of calcium sensing receptor trafficking by RAMPs.,
Adv Exp Med Biol 2012 ; 744(): 39-48.
2009
[Extranuclear functions of protein sumoylation in the central nervous system].,
Med Sci (Paris) 2009 ; 25(8-9): 693-8.
2009
Corticosterone alters AMPAR mobility and facilitates bidirectional synaptic plasticity.,
PLoS One 2009 ; 4(3): e4714.
2008
Bidirectional regulation of kainate receptor surface expression in hippocampal neurons.,
J Biol Chem 2008 Dec; 283(52): 36435-40.
2008
Regulation of calcium-sensing-receptor trafficking and cell-surface expression by GPCRs and RAMPs.,
Trends Pharmacol Sci 2008 Dec; 29(12): 633-9.
2008
Inhibition of Arp2/3-mediated actin polymerization by PICK1 regulates neuronal morphology and AMPA receptor endocytosis.,
Nat Cell Biol 2008 Mar; 10(3): 259-71.
2007
Emerging extranuclear roles of protein SUMOylation in neuronal function and dysfunction.,
Nat Rev Neurosci 2007 Dec; 8(12): 948-59.
2007
Retaining synaptic AMPARs.,
Neuron 2007 Sep; 55(6): 825-7.
2007
The calcium-sensing receptor changes cell shape via a beta-arrestin-1 ARNO ARF6 ELMO protein network.,
J Cell Sci 2007 Aug; 120(Pt 15): 2489-97.
2007
SUMOylation regulates kainate-receptor-mediated synaptic transmission.,
Nature 2007 May; 447(7142): 321-5.
2006
Internalization-dependent regulation of HT29 cell proliferation by neurotensin.,
Peptides 2006 Oct; 27(10): 2502-7.
2005
Receptor-activity-modifying proteins are required for forward trafficking of the calcium-sensing receptor to the plasma membrane.,
J Cell Sci 2005 Oct; 118(Pt 20): 4709-20.
2005
Neurotensin and the neurotensin receptor-3 in microglial cells.,
J Neurosci Res 2005 Aug; 81(3): 322-6.
2005
Syntenin is involved in the developmental regulation of neuronal membrane architecture.,
Mol Cell Neurosci 2005 Apr; 28(4): 737-46.
2004
Activity-dependent endocytic sorting of kainate receptors to recycling or degradation pathways.,
EMBO J 2004 Dec; 23(24): 4749-59.
2004
Internalization and trafficking of neurotensin via NTS3 receptors in HT29 cells.,
Int J Biochem Cell Biol 2004 Nov; 36(11): 2153-68.
2003
Involvement of the neurotensin receptor-3 in the neurotensin-induced migration of human microglia.,
J Neurosci 2003 Feb; 23(4): 1198-205.
2002
Neurotensin receptor-1 and -3 complex modulates the cellular signaling of neurotensin in the HT29 cell line.,
Gastroenterology 2002 Oct; 123(4): 1135-43.
2002
Recycling ability of the mouse and the human neurotensin type 2 receptors depends on a single tyrosine residue.,
J Cell Sci 2002 Jan; 115(Pt 1): 165-73.
2001
Pharmacological properties of the mouse neurotensin receptor 3. Maintenance of cell surface receptor during internalization of neurotensin.,
FEBS Lett 2001 Apr; 495(1-2): 100-5.
1999
Pivotal role of an aspartate residue in sodium sensitivity and coupling to G proteins of neurotensin receptors.,
Mol Pharmacol 1999 Feb; 55(2): 210-5.